Research Article
[Retracted] Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
Table 2
Comparison of general information of high-risk patients.
| Project | Group A (n = 67) | Group B (n = 81) | Group C (n = 74) | X2 | F value | value |
| Male (number/%) | 48 (71.6) | 56 (69.1) | 51 (68.9) | 1.93 | | 0.38 | Age (mean ± SD) | 63.23 ± 8.99 | 64.32 ± 8.94 | 63.45 ± 7.98 | | 0.15 | 0.89 | Tumor staging | | | | 2.14 | | 0.34 | Ta (number) | 29 | 30 | 36 | | | | T1 (number) | 38 | 51 | 38 | | | | Tumor grade | | | | 4.43 | | 0.11 | Low grade (number) | 34 | 40 | 48 | | | | High grade (number) | 33 | 41 | 26 | | | | Number of tumors | | | | 0.20 | | 0.90 | Single shot (number) | 29 | 38 | 33 | | | | Multiple shots (number) | 38 | 43 | 41 | | | |
|
|